GE HealthCare Technologies (GEHC) versus Its Competitors Head-To-Head Survey

GE HealthCare Technologies (NASDAQ:GEHC) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare GE HealthCare Technologies to similar businesses based on the strength of its profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Insider & Institutional Ownership

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares GE HealthCare Technologies and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
GE HealthCare Technologies	$20.62 billion	$2.08 billion	17.51
GE HealthCare Technologies Competitors	$1.89 billion	$136.85 million	5.95

GE HealthCare Technologies has higher revenue and earnings than its peers. GE HealthCare Technologies is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares GE HealthCare Technologies and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.96%	20.45%	5.97%
GE HealthCare Technologies Competitors	-300.62%	-179.55%	-22.71%

Risk and Volatility

GE HealthCare Technologies has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies’ peers have a beta of 5.41, suggesting that their average share price is 441% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for GE HealthCare Technologies and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0	11	12	0	2.52
GE HealthCare Technologies Competitors	4302	10596	18377	837	2.46

GE HealthCare Technologies currently has a consensus price target of $82.17, suggesting a potential downside of 1.02%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.54%. Given GE HealthCare Technologies’ peers higher possible upside, analysts plainly believe GE HealthCare Technologies has less favorable growth aspects than its peers.

Dividends

GE HealthCare Technologies pays an annual dividend of $0.16 per share and has a dividend yield of 0.2%. GE HealthCare Technologies pays out 3.4% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.2% and pay out 42.0% of their earnings in the form of a dividend. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

Summary

GE HealthCare Technologies beats its peers on 9 of the 15 factors compared.

About GE HealthCare Technologies

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.